I think it's persistence. The guy who ended up being our lead VC was someone we had worked with in the past. So he knew the founder and he knew me. When we first approached him we said vaccines in the developing world and you could almost see him go Aaaagh! In Biotech, vaccines weren't viewed as ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
